Rituximab shows promise for clinical problems tied to antiphospholipid antibodies Science Codex Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according ... |
